Speaker illustration

Doctor Jennifer Robinson

University of Iowa, Iowa (United States of America)

Dr. Robinson is the Director of the Preventive Research Center and has conducted numerous clinical trials of lipid-lowering, anti-atherosclerotic and metabolic agents, and postmenopausal hormone therapy sponsored by the National Institutes of Health and the pharmaceutical industry. She has published over 250 peer-reviewed articles in the area of lipids-modifying drugs, cardiovascular risk stratification, and cardiovascular prevention. Dr Robinson was the Vice Chair of the 2013 ACC/AHA Cholesterol Guideline, and a member of the 2013 ACC/AHA Risk Assessment Guideline. She has lectured widely on preventive cardiology and the diagnosis and treatment of lipid disorders.

Engaging patients to improve treatment adherence

Event: ESC Congress 2017

Topic: Lipids

Session type: Satellite Symposium - Experts on the Spot


ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb